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Abstract
The leading cause of pregnancy-associated mortality and morbidity is pre-eclampsia (PE). Although information regarding
the etiology of this disease is scant, its pathophysiology is characterized by abnormal placentation, endothelial dysfunction
as well as an exaggerated inflammatory response. Clinical evidence also indicates that the abundance of many immune cells
at the feto-maternal interface and in the circulation of PE patients is abnormal, when compared with normal pregnant (NP)
controls. In addition, the phenotype and function of some of these cells is altered. To further characterize the systemic
effects of PE on circulating cells, we analyzed monocytic subpopulations in NP and PE patients by flow cytometry. We found
that non-classical CD14lowCD16+ monocytes are significantly increased in women with PE and they display irregular
expression of several chemokine receptors and antigen presentation molecules. The most striking phenotypic difference
among the cell surface molecules was the marked upregulation of TLR4 expression, where both CD14highCD16+ and
CD14lowCD16+ monocytes demonstrated higher levels than their NP counterparts. Stimulation of PE monocytes with TLR
ligands resulted in profound secretion of various cytokines in comparison with NP controls. These data suggest that PE
monocytes are hyper-responsive to TLR ligands and this may contribute to exacerbation of the disease.
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Introduction
Pre-eclampsia (PE) is a potentially life-threatening, pregnancy
disorder characterized by new onset of hypertension and
proteinuria after 20 weeks gestation [1]. The incidence of PE is
common varying between 2–7% of healthy primigravid women
[2]. Abnormal placentation [3,4], endothelial dysfunction [5–7] as
well as an exaggerated inflammatory response [8,9] are thought to
be the basis of the clinical manifestations of PE. However, the
underlying cause(s) of PE remain unknown and its pathogenesis
remains poorly understood.
During pregnancy, innate immune cells are abundantly present
at the feto-maternal interface where they are thought to facilitate
implantation, aid in placental development and maintain fetal
tolerance [10]. The perturbation of this feto-maternal immune
system has been recognized for some time now in PE patients. In
the circulation, both monocytes and granulocytes display aberrant
expression levels of surface antigens, cytokines and reactive oxygen
species [11–14]. For example, monocytes display increased
expression of CD14 and CD11b and produce more interleukin
(IL)-1b, IL-6 and IL-8 than healthy pregnancy controls [11–14].
These phenotypic changes are thought to affect monocytes in
several ways, including their adherence to the vasculature as well
as a down-regulation in their immunosuppressive functions once
localized at the feto-maternal interface [15]. In support of these
notions, several studies have reported abnormal numbers of
decidual macrophages [16–18] and decreased expression of the
immunosuppressive cytokine, IL-10, in PE maternal blood serum
compared to normal pregnancy controls [19,20]. As monocytes
and macrophages are critical for successful pregnancy, we set out
to further characterize the monocyte phenotype in PE patients.
Monocytes in human peripheral blood can be divided into three
distinct populations based on expression of the lipopolysaccharide
(LPS) receptor, CD14, and the Fcc-III receptor, CD16. The
nomenclature and classification of these monocyte subsets has
recently been updated into three populations: classical monocytes
(CD14highCD162), intermediate monocytes (CD14highCD16+),
and non-classical monocytes (CD14lowCD16+) [21]. Emerging
evidence indicates that each subpopulation has a unique gene
signature and may also have differential functions in inflammation
and immunity [22,23]; although, the hierarchical relationship and
differentiation lineage between the subpopulations is still unclear.
In this study, we report that the proportion of non-classical
CD14lowCD16+ monocytes in PE patients is increased, while
classical CD14highCD162 monocytes are decreased in comparison
with normal pregnant (NP) controls. The phenotype of PE
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monocytes was also altered, exhibiting aberrant expression of
chemokine receptors, antigen presentation molecules, and Toll-
like receptors (TLR). Moreover, treatment of PE monocytes with
TLR ligands resulted in an exaggerated production of pro- and
anti-inflammatory cytokines. These results provide further evi-
dence that the phenotype of monocytes in PE patients is abnormal
and this may exacerbate the problems associated with PE.
Materials and Methods
Ethics Statement
Ethical approval for this study was received from South
Yorkshire Research Ethics Committee (09/H1310/12).
Subjects
Women with established pre-eclampsia were diagnosed by the
criteria of the International Society for the Study of Hypertension
in Pregnancy (ISSHP) [24], and were recruited from the antenatal
clinics and obstetric day care unit of the Jessop Wing, University of
Sheffield. Healthy non-pregnant (Non-P) female volunteers were
also studied to determine baseline non-gestational levels. The
Non-P women had normal menstrual cycles and were not on
hormonal contraception (Table 1). Our NP cohort included 10
Caucasian women and 1 black woman and the PE cohort included
15 Caucasian women and 2 black women. No study participants
had any systemic infection or urinary tract infection. All
participants gave informed written consent for 12 mL of fresh
venous blood to be collected into a tube containing EDTA
anticoagulant.
Flow Cytometry
Peripheral blood mononuclear cells (PBMCs) were isolated from
fresh venous blood layered over Ficoll-Pague Plus (Amersham
Biosciences) which was centrifuged for 20 min at 800 6 g. The
white layer was removed and washed twice with HBSS +0.5%
BSA as previously described [25]. The cells were blocked with
5 mL of anti-human Fc receptor blocking reagent (Miltenyi Biotic,
Surrey) for 10 minutes at 4uC. PBMCs were labelled with the
following monoclonal antibodies for 30 minutes at 4uC: anti-
CD14-AlexaFluor700 (clone HCD14; Biolegend), anti-CD16-
eFlour450 (clone CB16; eBioscience), anti-CCR2-PE (clone
FAB151P; R&D Systems), anti-CCR5-FITC (clone HEK/1/
85a; Biolegend), anti-HLA-DR-PerCP-Cy5.5 (clone LN3;
eBioscience), anti-TIE2-APC (clone FAB3131A; R&D Systems),
anti-TLR2-FITC (clone TL2.1; eBioscience), and anti-TLR4-PE
(clone HTA125; eBioscience). PBMCs were also labelled with
isotype negative controls. Cells were washed twice by cold BD flow
cytometry stain buffer, before acquisition was done on a LSRII
Flow Cytometer (BD Bioscience). DIVA software (BD Bioscience)
was used for analysis. Compensation was calculated using anti-
mouse compensation bead sets (BD Bioscience). A gate specific for
the monocyte population was created on the forward scatter (FSC)
and side scatter (SSC) dot plot and a total of 10,000 events were
acquired. Monocyte sub-populations were identified according to
CD14 and CD16 surface markers as defined previously
[21,26,27].
Monocyte Stimulation
Isolated PBMCs were seeded in 12-well tissue culture flat
bottom plates at a density of 1.8 6 106 cells/well. The cells were
incubated with medium (IMDM supplemented with 2% FBS,
2 mM L-Glutamine and penicillin-streptomycin) at 37uC with 5%
CO2 After two hours of incubation the medium was removed and
the adherent monocytes were washed twice with cold PBS. The
medium was then replaced. Cells were treated with 100 ng/ml
Lipopolysaccharides (rough strains) from Escherichia coli (Sigma-
Aldrich), 5 mg/ml Peptidoglycan from Staphylococcus aureus (Sigma-
Aldrich) or left untreated for 24 hours. Conditioned medium was
collected after this time and frozen at 220uC.
Cytometric Bead Array
Cytometric bead array technique was used to measure IL-6,
TNFa and IL-10 cytokines within monocyte conditioned medium.
This assay was performed following the manufacturer’s instruc-
tions (BD Biosciences) at the Flow Cytometry Core Facility in the
Sheffield University Medical School. BD FACS Array flow
cytometry machine and FCAP Array software were used for
analysis. To calculate fold change, the median fluorescence
intensity (MFI) of LPS- or PDG-treated was divided over the
unstimulated MFI.
Statistical Analysis
Results are illustrated as mean 6 standard error of the mean
(SEM). Mann-Whitney U-test was used to compare differences
between Non-P and NP or NP and PE using GraphPad Prism
software version 5.0. P values , 0.05 were considered significantly
different.
Results
Monocyte Subpopulation Frequency is Skewed in
Pregnant Women with PE
Blood samples were collected from non-pregnant (Non-P),
normal pregnant (NP), and pregnant women with pre-eclampsia
(PE). Peripheral blood mononuclear cells (PBMCs) were isolated
from these samples, stained with anti-CD14 and anti-CD16
Table 1. Patient characteristics.
Non-pregnant (n = 11) Normal pregnant (n = 11) Pre-eclampsia (n = 17) P value
Age (years) 31.065.4 29.364.9 31.465.6 0.26
Gestational age (weeks) 32.063.7 32.963.7 0.38
Gravidity 1–4 1–4
SBP (mm Hg) 110.0610.0 114.0611.0 150.468.6 0.0001
DBP (mm Hg) 70.0610.0 70.0610.0 98.364.2 0.0001
24 hour urine collection (g/24 hrs) 0 0 0.8461.3
Urine Dipstick Protein Test 0 0 (1+–3+)
doi:10.1371/journal.pone.0042217.t001
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antibodies, and analyzed by flow cytometry. Gates were first
placed around monocytes on FSC/SSC plots. No difference in the
total number of monocytes amongst all PBMCs was noted
between the three groups (data not shown). By contrast, differences
in monocyte subpopulations were prevalent between the three
groups (Figure 1). NP patients exhibited a greater proportion of
CD14highCD16– monocytes and a lower proportion of
CD14lowCD16+ monocytes when compared with Non-P patients.
Interestingly, this pattern was reversed in women with PE, where
the non-classical CD14lowCD16+ monocytes were significantly
increased over NP controls. No differences were observed in the
intermediate CD14highCD16+ monocyte population between any
of the patients.
PE is Associated with Changes in Monocyte Phenotype
Next, we investigated the phenotype of monocytes in Non-P,
NP, and PE women. In relation to Non-P patients, the monocytes
of NP patients expressed lower levels of CCR2 and CCR5, but
higher levels of HLA-DR, TIE2 and TLR2 (Figure 2). The
number of TLR4+ monocytes was equivalent between the two
groups. When comparing NP and PE monocytes, PE patients
displayed a reduced number of HLA-DR+ and TIE2+ monoyctes,
whereas CCR5+ and TLR4+ monocytes were dramatically
increased (Figure 2). A similar expression profile for CCR2 and
TLR2 was observed between the two groups. These data indicate
that monocytes from PE patients are phenotypically different from
NP patients.
To determine whether the differences we observed were due
to changes in expression by specific monocyte subpopulations,
we examined the phenotypic markers on classical, intermediate,
and non-classical subpopulations. Interestingly, classical mono-
cytes did not exhibit any differences between the three patient
cohorts. All the observed changes could be attributed to
intermediate or non-classical monocytes. Expression levels of
Figure 1. The proportion of monocyte subpopulations is skewed in patients with PE. PBMCs from non-pregnant (Non-P), normal pregnant
(NP), and pre-eclampsia (PE) patients were stained with anti-CD14-AlexaFluor700 and anti-CD16-eFluor450 antibodies then analyzed by flow
cytometry. (A) Dot plots showing CD14 and CD16 expression on gated monocytes. (B) Graphic representation of percentage of gated cells (mean 6
SEM). Statistical significance was determined by Mann-Whitney U test (n = 11217). **p , 0.01, ***p , 0.001 as compared with Non-P; {{{p , 0.001 as
compared with NP.
doi:10.1371/journal.pone.0042217.g001
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CCR2, HLA-DR, and TLR2 were not different among
monocytic subpopulations of NP and PE patients (Figure 3).
However, the intermediate CD14highCD16+ monocyte popula-
tion of PE patients displayed higher expression of CCR5 and
TLR4 than NP patients. TLR4 was also significantly increased
on non-classical CD14lowCD16+ monocytes from PE when
compared with NP controls. Moreover, TIE2 expression was
significantly reduced on the CD14lowCD16+ monocytes subset
in PE. These data suggest that phenotypic differences between
NP and PE patients can be attributed to specific monocyte
subpopulations.
Monocytes from PE Patients Exhibit an Amplified
Response to TLR Ligands
Since TLR4 expression was increased on PE monocytes, we
asked whether the observed phenotypic changes have any
consequence on monocyte activity. We treated monocytes from
Non-P, NP, and PE patients with TLR4 ligands and monitored
cytokine expression. Without stimulation, IL-6, IL-10 and TNFa
release by PE monocytes was reduced in relation to NP; although,
only IL-10 secretion was significantly reduced (Figure 4).
Lipopolysaccharide (LPS) and peptidoglycan (PDG) significantly
induced all three cytokines in each patient cohort when compared
to unstimulated, control groups. However, TLR ligand-treated PE
monocytes exhibited a marked and significant increase over that
seen in TLR ligand-treated NP monocytes. Taken together, these
data indicate that increased expression of TLR4 on monocytes
from PE patients results in an exaggerated response to TLR4
ligands.
Discussion
Evidence from PE patients indicates that their circulating
monocytes display an aberrant activation status, with altered
expression levels of surface antigens, cytokines and reactive oxygen
species when compared with healthy pregnancy controls [11–14].
This report supports previously published findings and provides
additional data describing the proportional and phenotypic
differences between monocyte subpopulations of PE and NP
women. We found that the non-classical, CD14lowCD16+ mono-
cyte subpopulation is increased in PE patients where they exhibit
lower expression levels of HLA-DR and TIE2, and higher levels of
CCR5 and TLR4.
Figure 2. NP and PE monocytes display marked phenotypic differences. PBMCs from non-pregnant (Non-P), normal pregnant (NP), and pre-
eclampsia (PE) patients were stained with anti-CD14-AlexaFluor700, anti-CD16-eFluor450, anti-CCR2-PE, anti-CCR5-FITC, anti-HLA-DR-PerCP-Cy5.5,
anti-TIE2-APC, anti-TLR2-FITC, and anti-TLR4-PE antibodies then analyzed by flow cytometry. Gates were placed around monocytes on FSC/SSC plots
and the percentage of positive cells was calculated based off isotype controls. Values are illustrated as mean 6 SEM. Statistical significance was
determined by Mann-Whitney U test (n = 5216). n.s. = not significant, **p,0.01, ***p,0.001 as compared with Non-P; {p,0.05, {{p,0.01, {{{p,0.001
as compared with NP.
doi:10.1371/journal.pone.0042217.g002
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The elevation of CD14lowCD16+ monocytes has been reported
in other diseases such as rheumatoid arthritis, atherosclerosis,
Kawasaki disease, septic shock and human immunodeficiency
virus (HIV) infection [27–33]. As such, expansion of non-classical
monocytes may be a general phenomenon of inflammatory and
infectious diseases. However, their role in the manifestation or
propagation of these diseases is unclear, as very little is known
about CD14lowCD16+ monocyte function. After adoptive transfer
into immunocompromised mice, these cells attach to the
endothelium, crawl along vessels and exhibit a ‘patrolling’
behavior whereas classical and intermediate monocytes do not
[23]. CD14lowCD16+ monocytes from healthy non-pregnant
patients are weakly phagocytic of latex beads and give little
response to LPS stimulation [23].
Our data indicate that CD14lowCD16+ monocytes of PE
women upregulate TLR4 and exhibit an exaggerated response
to LPS. Increased TLR4 levels have also been observed on
neutrophils of PE women [34], suggesting that induction of TLR4
expression on circulating myeloid cells is a specific consequence of
PE pathophysiology. It is tempting to speculate that a trigger
factor(s) released by an abnormally ischemic placenta may be
inducing early monocyte maturation – such as CD14highCD16–
monocyte differentiation into CD14lowCD16+ monocytes – and/
or upregulation of TLR4. In support of this notion, placental
microparticles, namely syncytiotrophoblast basement membrane
fragments derived from human term placentas, activate cytokine
release from peripheral blood monocytes [35] and plasma from PE
patients can induce ICAM-1, an adhesion receptor, in a
monocytic cell line [36]. It will be interesting to determine
whether TLR4 expression on newly recruited decidual macro-
phages correlates with TLR4 expression on circulating monocytes
and whether signalling through this receptor exacerbates PE in
murine models.
In contrast to our findings and others [34], studies have also
reported reduced expression of TLR4 mRNA in neutrophils of PE
women [37] and impaired secretion of TNFa after LPS and PDG
treatment of PE monocytes [38]. The results from these studies
may be difficult to compare as gestational age, severity of the
disease (i.e. proteinuria), gravidity, and genetic background of each
patient population is dramatically different. Moreover, the
concentration of TLR4 ligands as well as the bacterial source of
the ligands is widely different among various studies. These
dissimilarities strongly suggest caution is warranted when inter-
preting this type of data.
In addition to TLR4, we observed differences in CCR5,
HLA-DR, and TIE2 between PE and NP patients; although,
Figure 3. Expression of phenotypic markers on monocyte subpopulations. PBMCs from non-pregnant (Non-P), normal pregnant (NP), and
pre-eclampsia (PE) patients were stained with anti-CD14-AlexaFluor700, anti-CD16-eFluor450, anti-CCR2-PE, anti-CCR5-FITC, anti-HLA-DR-PerCP-
Cy5.5, anti-TIE2-APC, anti-TLR2-FITC, and anti-TLR4-PE antibodies then analyzed by flow cytometry. Gates were placed around CD14/CD16 monocyte
subpopulations and median fluorescence intensity (MFI) was calculated based off isotype controls. Values are illustrated as mean 6 SEM. Statistical
significance was determine by Mann-Whitney U test (n = 7217). *p,0.05, **p,0.01 as compared with Non-P; {p,0.05, {{p,0.01 as compared with
NP.
doi:10.1371/journal.pone.0042217.g003
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the ramifications of their altered expression is also unclear.
CCR5 binds the chemokine CCL5/RANTES which activates
signalling pathways leading to migration. In our study, CCR5
upregulation was specific to the intermediate CD14highCD16+
monocytes, indicating that this subpopulation may be recruited
by CCL5 expression in the placenta. HLA-DR was found at
reduced levels in PE and may affect T cell activation in these
patients, as this molecule is important for antigen presentation.
Of note, TIE2-expressing monocytes have been shown to
promote angiogenesis in mouse tumor models [25,39], so their
decrease in PE could have major implications for the reduced
oxygenation observed in PE. All of these hypotheses remain to
be tested.
In conclusion, the alterations of monocyte subpopulations seen
in PE with predominance of CD14lowCD16+ monocytes may
result in the disturbance of decidual leukocyte distribution and
function. Also, the upregulation of TLR4 suggests a role for this
pattern recognition receptor in the exaggerated systemic inflam-
matory response seen in PE but it is unclear whether this occurs as
a cause or consequence of PE.
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Figure 4. Monocytes from PE patients exhibit an amplified response to TLR ligands. Monocytes from non-pregnant (Non-P), normal
pregnant (NP), and pre-eclampsia (PE) patients were isolated, seeded onto tissue culture plates, then treated with 100 ng/mL LPS or 5 mg/mL
peptidoglycan (PDG) for 24 hours. Conditioned medium was collected after this time and analyzed by cytometric bead array to measure cytokine
levels. left panels: Basal levels of cytokine production by monocytes. right panels: Graphic representation of the response of monocytes to LPS and
PDG. Fold change was calculated by dividing MFI values over untreated control MFI values and illustrated as mean 6 SEM. Comparisons were made
between NP and PE fold changes. Statistical significance was determined by Mann-Whitney U test (n$5). {p,0.05, {{p,0.01 as compared with NP.
doi:10.1371/journal.pone.0042217.g004
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